A detailed history of Eagle Rock Investment Company, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eagle Rock Investment Company, LLC holds 44,188 shares of BMY stock, worth $2.57 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
44,188
Previous 35,192 25.56%
Holding current value
$2.57 Million
Previous $1.46 Million 56.47%
% of portfolio
0.39%
Previous 0.27%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$39.66 - $51.75 $356,781 - $465,543
8,996 Added 25.56%
44,188 $2.29 Million
Q2 2024

Jul 12, 2024

SELL
$40.25 - $52.99 $1.2 Million - $1.58 Million
-29,735 Reduced 45.8%
35,192 $1.46 Million
Q1 2024

Apr 15, 2024

BUY
$47.98 - $54.4 $757,028 - $858,323
15,778 Added 32.1%
64,927 $3.52 Million
Q4 2023

Jan 12, 2024

SELL
$48.48 - $57.85 $1.94 Million - $2.31 Million
-39,937 Reduced 44.83%
49,149 $2.52 Million
Q3 2023

Oct 10, 2023

SELL
$57.89 - $64.73 $5,094 - $5,696
-88 Reduced 0.1%
89,086 $5.17 Million
Q2 2023

Jul 19, 2023

SELL
$63.71 - $70.74 $110,727 - $122,946
-1,738 Reduced 1.91%
89,174 $5.7 Million
Q1 2023

Apr 10, 2023

SELL
$65.71 - $74.53 $50,465 - $57,239
-768 Reduced 0.84%
90,912 $6.3 Million
Q4 2022

Jan 25, 2023

SELL
$68.48 - $81.09 $27,323 - $32,354
-399 Reduced 0.43%
91,680 $0
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $730 - $432,071
-5,623 Reduced 5.76%
92,079 $6.55 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $1.21 Million - $1.33 Million
-16,640 Reduced 14.55%
97,702 $7.52 Million
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $2.85 Million - $3.41 Million
-46,284 Reduced 28.81%
114,342 $8.35 Million
Q4 2021

Feb 17, 2022

BUY
$53.63 - $62.52 $8.61 Million - $10 Million
160,626 New
160,626 $10 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Eagle Rock Investment Company, LLC Portfolio

Follow Eagle Rock Investment Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Rock Investment Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Rock Investment Company, LLC with notifications on news.